February 6th 2025
Learn more about Sports Psychiatry Section Editor Wilsa M. S. Charles Malveaux, MD, MA, FAPA, and her path to sports psychiatry.
January 23rd 2025
Here's how best to manage polypharmacy in patients with traumatic brain injury.
More Than ‘Blue’ After Birth: Managing Diagnosis and Treatment of Post-Partum Depression
View More
Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans
View More
Expert Perspectives in the Recognition and Management of Postpartum Depression
View More
Southern California Psychiatry Conference
July 11-12, 2025
Register Now!
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Expert Illustrations & Commentaries™: New Targets for Treatment in Cognitive Impairment in Schizophrenia – The Role of NMDA Receptors and Co-agonists
View More
BURST CME™ Part I: Understanding the Impact of Huntington’s Disease
View More
Burst CME™ Part II: The Evolving Treatment Landscape for Huntington Disease
View More
Study Sheds Light on Social Drivers That Increase Risk of Suicide
January 31st 2025Yale School of Medicine and VA Connecticut Healthcare System researchers compared social determinants of health in relation to the risk of suicide, a major global public health issue and one of the leading causes of death in the United States.
Current and emerging treatments for PPD
January 31st 2025Melanie Barrett, MD; Anita Clayton, MD, and Carmen Kosicek, MSN, PMHNP-BC, discuss how postpartum depression treatments are evolving beyond traditional antidepressants to include rapid-acting options like brexanolone and zuranolone, along with enhanced screening and support programs for new mothers.
Yale-Led Study Will Compare Effectiveness of IV Ketamine and Esketamine Nasal Spray
January 30th 2025Patients are now being recruited for a study to compare the effectiveness of IV ketamine and esketamine nasal spray (otherwise known as Spravato) for people who suffer from treatment-resistant depression.